Genome-wide association and multi-omics studies identify MGMT as a novel risk gene for Alzheimer’s disease among women.

Variants in the tau gene (MAPT) region are associated with breast cancer in women and Alzheimer’s disease (AD) among persons lacking apolipoprotein E ε4 (ε4-).